Skip to main content
CivixlyCivixly
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Account
Menu
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Account
Civixly

Find representatives, follow federal and state legislation, and connect public records to the people and institutions responsible for them.

Explore

Federal governmentState governmentCivics guidesInstall Civixly

About the data

About CivixlyMethodologyData sources

Trust and support

Send feedback or a correctionPrivacy and data controlsSecurity contactCommunity

State Government / Hawaii / Legislation / HB 1550

HB 1550Session 2026HousePassed a vote

RELATING TO HEALTH.

Source-provided summary

Excludes drug testing products from the definition of drug paraphernalia under the Uniform Controlled Substances Act. Removes items that are used to plant, propagate, cultivate, grow, harvest, test, analyze, pack, repack, store, contain, conceal, inject, ingest, inhale, or otherwise introduce into the human body a controlled substance from the law prohibiting drug paraphernalia under the Uniform Controlled Substances Act. Restricts the law prohibiting drug paraphernalia under the Uniform Controlled Substances Act to only prohibit items that are used for the manufacturing, compounding, converting, production, processing, or preparing of controlled substances. Repeals language permitting the Department of Health to inspect a qualifying patient's medical records and suspend or revoke the ability of certain health care providers to issue written certifications under certain circumstances. (CD1)

Latest development · May 6, 2026

Failed to pass Final Reading. Ayes, 9; Aye(s) with reservations: none. Noes, 16 (Senator(s) Awa, Chang, DeCorte, Dela Cruz, Elefante, Fevella, Gabbard, Hashimoto, Inouye, Kidani, Kim, Lamosao, Lee, C., McKelvey, Moriwaki, Wakai). Excused, 0 (none).

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Source record ↗
Session
2026
Introduced
Jan 15, 2026
Latest passage
Apr 14, 2026
TopicsSponsorsActionsRelated billsDiscussion

Topics and classification

Civixly topics

Health

Source subjects

DOHDrug ParaphernaliaDrug Testing ProductsInspectionMedical CannabisMedical RecordsQualifying PatientsUniform Controlled Substances Act

Document type

Bill

Sponsors

Primary sponsors are listed before cosponsors and other sponsoring entities.

Primary sponsorAMATO
Primary sponsorEVSLIN
Primary sponsorILAGAN
Primary sponsorIWAMOTO
Primary sponsorKEOHOKAPU-LEE LOY
Primary sponsorKUSCH
Primary sponsor

LEE

Primary sponsor

M.

Primary sponsorMARTEN
Primary sponsorMATAYOSHI
Primary sponsorOLDS
Primary sponsorPERRUSO
Primary sponsorSOUZA
Primary sponsorTAKAYAMA
Primary sponsorTARNAS
cosponsorPoepoe

Action timeline

Newest action first. Action language is supplied by the state source.

View full action timeline40 actions⌄
  1. May 6, 2026

    Failed to pass Final Reading. Ayes, 9; Aye(s) with reservations: none. Noes, 16 (Senator(s) Awa, Chang, DeCorte, Dela Cruz, Elefante, Fevella, Gabbard, Hashimoto, Inouye, Kidani, Kim, Lamosao, Lee, C., McKelvey, Moriwaki, Wakai). Excused, 0 (none).

    Senate
  2. May 6, 2026

    Recommitted to Conference committee as amended in CD 1 with none voting no and Representative(s) Alcos excused.

    House
  3. Apr 29, 2026

    The Conference committee recommends that the measure be PASSED, WITH AMENDMENTS. The votes of the Senate Conference Managers were as follows: 3 Aye(s): Senator(s) San Buenaventura, Rhoads, McKelvey; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

    Committee Passage FavorableSenate
  4. Apr 29, 2026

    The Conference Committee recommends that the measure be Passed, with Amendments. The votes were as follows: 4 Ayes: Representative(s) Takayama, Tarnas, Keohokapu-Lee Loy; Ayes with reservations: Representative(s) Garcia; 0 Noes: none; and 0 Excused: none.

    Committee Passage FavorableHouse
  5. Apr 29, 2026

    Reported from Conference Committee (Conf Com. Rep. No. 80-26) as amended in (CD 1).

    House
  6. Apr 29, 2026

    Forty-eight (48) hours notice Wednesday, 05-06-26.

    House
  7. Apr 29, 2026

    Reported from Conference Committee as amended CD 1 (Conf. Com. Rep. No. 80-26).

    Senate
  8. Apr 29, 2026

    48 Hrs. Notice (as amended CD 1) 05-06-26

    Senate
  9. Apr 28, 2026

    Conference committee meeting scheduled for 04-29-26 3:45PM; CR 329.

    Senate
  10. Apr 27, 2026

    Senate Conferees Appointed: San Buenaventura Chair; Rhoads Co-Chair; McKelvey.

    Senate
  11. Apr 27, 2026

    Received notice of Senate conferees (Sen. Com. No. 778).

    ReceiptHouse
  12. Apr 21, 2026

    House Conferees Appointed: Takayama, Tarnas Co-Chairs; Keohokapu-Lee Loy, Garcia.

    House
  13. Apr 21, 2026

    Received notice of appointment of House conferees (Hse. Com. No. 799).

    ReceiptSenate
  14. Apr 17, 2026

    Received notice of disagreement (Hse. Com. No. 780).

    ReceiptSenate
  15. Apr 16, 2026

    House disagrees with Senate amendment (s).

    Amendment FailureHouse
  16. Apr 14, 2026

    Report adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

    PassageSenate
  17. Apr 14, 2026

    Returned from Senate (Sen. Com. No. 584) in amended form (SD 2).

    House
  18. Apr 10, 2026

    Reported from JDC (Stand. Com. Rep. No. 3764) with recommendation of passage on Third Reading, as amended (SD 2).

    Senate
  19. Apr 10, 2026

    48 Hrs. Notice 04-14-26.

    Senate
  20. Apr 1, 2026

    The committee(s) on JDC recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in JDC were as follows: 4 Aye(s): Senator(s) Rhoads, Chang, San Buenaventura, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Gabbard.

    Committee Passage FavorableSenate
  21. Mar 30, 2026

    The committee(s) on JDC will hold a public decision making on 04-01-26 10:40AM; Conference Room 016 & Videoconference.

    Senate
  22. Mar 25, 2026

    Reported from HHS (Stand. Com. Rep. No. 3191) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC.

    Senate
  23. Mar 25, 2026

    Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC.

    PassageReading 2Referral CommitteeSenate
  24. Mar 20, 2026

    The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) McKelvey.

    Committee Passage FavorableSenate
  25. Mar 17, 2026

    The committee(s) on HHS has scheduled a public hearing on 03-20-26 1:00PM; Conference Room 225 & Videoconference.

    Senate
  26. Mar 12, 2026

    Received from House (Hse. Com. No. 243).

    IntroductionReceiptSenate
  27. Mar 12, 2026

    Passed First Reading.

    Reading 1Senate
  28. Mar 12, 2026

    Referred to HHS, JDC.

    Referral CommitteeSenate
  29. Mar 10, 2026

    Passed Third Reading as amended in HD 2 with Representative(s) Garcia, Kila voting aye with reservations; Representative(s) Pierick voting no (1) and none excused (0). Transmitted to Senate.

    PassageHouse
  30. Mar 6, 2026

    Reported from JHA (Stand. Com. Rep. No. 1149-26) as amended in HD 2, recommending passage on Third Reading.

    House
  31. Mar 6, 2026

    Forty-eight (48) hours notice Tuesday, 03-10-26.

    House
  32. Feb 25, 2026

    The committee on JHA recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Tarnas, Poepoe, Cochran, Hashem, Kahaloa, Sayama, Takayama, Garcia, Shimizu; Ayes with reservations: none; 0 Noes: none; and 1 Excused: Representative(s) Belatti.

    Committee Passage FavorableHouse
  33. Feb 23, 2026

    Bill scheduled to be heard by JHA on Wednesday, 02-25-26 2:00PM in House conference room 325 VIA VIDEOCONFERENCE.

    House
  34. Feb 18, 2026

    Reported from HLT (Stand. Com. Rep. No. 359-26) as amended in HD 1, recommending passage on Second Reading and referral to JHA.

    House
  35. Feb 18, 2026

    Passed Second Reading as amended in HD 1 and referred to the committee(s) on JHA with none voting aye with reservations; Representative(s) Pierick voting no (1) and none excused (0).

    Reading 2Referral CommitteeHouse
  36. Feb 13, 2026

    The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Hartsfield, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.

    Committee Passage FavorableHouse
  37. Feb 10, 2026

    Bill scheduled to be heard by HLT on Friday, 02-13-26 9:00AM in House conference room 329 VIA VIDEOCONFERENCE.

    House
  38. Jan 26, 2026

    Referred to HLT, JHA, referral sheet 1

    Referral CommitteeHouse
  39. Jan 21, 2026

    Introduced and Pass First Reading.

    IntroductionReading 1House
  40. Jan 15, 2026

    Prefiled.

    House

Related Hawaii legislation

Other measures from this legislative session that share one or more Civixly topics with HB 1550.

SB 847Updated Jul 16, 2026

RELATING TO PSYCHOLOGISTS.

Health
SB 2272Updated Jun 9, 2026

RELATING TO HOME HEALTH LICENSING.

Health
GM 556Updated Apr 30, 2026

Submitting for consideration and confirmation to the State Council on Mental Health, Gubernatorial Nominee, MARY PAT WATERHOUSE, for a term to expire 06-30-2028.

Health
SCR 45Updated Apr 10, 2026

SUPPORTING THE DEPARTMENT OF HEALTH'S EFFORTS TO COORDINATE THE STOCKPILING OF A THREE-YEAR SUPPLY OF MIFEPRISTONE.

Health
Browse all Hawaii legislation →

HB 1550 discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

State legislative data provided by Open States and linked legislature sources when available.

Civixly tracks state bill actions, passage dates, and sponsors. Member-level state roll-call histories are not included.

Source data last updated Jul 15, 2026.